臨床外科77巻1号

2022年01月発行

特集 外科医が知っておくべき—《最新版》栄養療法

総論

糖尿病と外科手術

著者： 谷岡信寿¹ 花﨑和弘¹

所属機関： ¹高知大学医学部外科学講座（消化器外科学，乳腺・内分泌外科学，小児外科学）

ページ範囲：P.30 - P.33

文献概要

【ポイント】
◆糖尿病患者は近年増加傾向にあり，周術期の血糖管理を難しくしている．
◆周術期は厳密な血糖管理が望ましいものの，ガイドラインでは重症低血糖のリスク回避の観点から比較的緩やかな血糖管理が推奨されている．
◆人工膵臓療法は厳密な血糖管理，重症低血糖の回避，血糖変動の抑制を可能にする．さらに医療スタッフの労働負担軽減効果や詳細なデータ収集機能などの利点は，今後の周術期血糖管理の進展に寄与することが期待される．

参考文献

1）清野　裕，南條輝志男，田嶼尚子，他：糖尿病の分類と診断基準に関する委員会報告（国際標準化対応版）．糖尿病55：485-504，2012

2）厚生労働省政策統括官付政策評価官室：糖尿病患者数の状況．厚生労働省，2019-02-08．https://www.mhlw.go.jp/stf/wp/hakusyo/kousei/18/backdata/01-01-02-08.html，（2021年8月1日閲覧）

3）Hanazaki K, Maeda H, Takehiro O：Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol 15：4122-4125, 2009

4）門脇さゆり，横山武志：麻酔科医が行うべき周術期糖代謝管理．体液代謝管理36：56-65，2020

5）Bucerius J, Gummert JF, Walther T, et al：Impact of diabetes mellitus on cardiac surgery outcome. Thorac Cardiovasc Surg 51：11-16, 2003

6）Carpenter DL, Gregg SR, Xu K, et al：Prevalence and impact of unknown diabetes in the ICU. Crit Care Med 43：e541-e550, 2015

7）Bennett SR, Alayesh YM, Algarni AM, et al：Effect of acute stress glycemic control and long-term glycemic control on the incidence of post-operative infection in diabetics undergoing cardiac surgery. Cureus 13：e14031, 2021

8）van den Berghe G, Wouters P, Weekers F, et al：Intensive insulin therapy in critically ill patients. N Engl J Med 345：1359-1367, 2001

9）NICE-SUGAR study investigators：Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360：1283-1297, 2009

10）Pezzella AT, Holmes SD, Pritchard G, et al：Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Ann Thorac Surg 98：1281-1285, 2014

11）Kao LS, Meeks D, Moyer VA, et al：Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev（3）：CD006806, 2009

12）Kumar SS, Pelletier SJ, Shanks A, et al：Intraoperative glycemic control in patients undergoing Orthotopic liver transplant：a single center prospective randomized study. BMC Anesthesiol 20：3, 2020

13）Umpierrez G, Cardona S, Pasquel F, et al：Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery：GLUCO-CABG trial. Diabetes Care 38：1665-1672, 2015

14）Sathya B, Davis R, Taveira T, et al：Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes：a meta-analysis. Diabetes Res Clin Pract 102：8-15, 2013

15）Ban KA, Minei JP, Laronga C, et al；American College of Surgeons and Surgical Infection Society：Surgical site infection guidelines, 2016 update. J Am Coll Surg 224：59-74, 2016

16）World Health Organization：Global guidelines on the prevention of surgical site infection. World Health Organization, Geneva, 2016

17）Berrios-Torres SI, Umscheid CA, Bratzler DW, et al：Centers for Disease Control and Prevention guideline for the prevention of surgical site infection. JAMA Surg 152：784-791, 2017

18）日本外科感染症学会（編）；消化器外科SSI予防のための周術期管理ガイドライン2018．診断と治療社，2018，pp 159-161

19）Egi M, Bellomo R, Stachowski E, et al：Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105：244-252, 2006

20）Akirov A, Shochat T, Dotan I, et al：Glycemic variability and mortality in patients hospitalized in general surgery wards. Surgery 166：184-192, 2019

21）Monnier L, Mas E, Ginet C, et al：Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295：1681-1687, 2006

22）Hermanides J, Vriesendorp TM, Bosman RJ, et al：Glucose variability is associated with intensive care unit mortality. Crit Care Med 38：838-842, 2010

23）Issarawattana T, Bhurayanontachai R：Maximal glycemic difference, the possible strongest glycemic variability parameter to predict mortality in ICU patients. Crit Care Res Pract 2020：5071509, 2020

24）Lal A, Haque N, Lee J, et al：Optimal blood glucose monitoring interval for insulin infusion in critically ill non-cardiothoracic patients：a pilot study. Acta Biomed 92 e2021036, 2021

25）Hanazaki K, Kitagawa H, Yatabe T, et al：Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system：the effects of no hypoglycemia. Am J Surg 207：935-941, 2014

26）Hanazaki K, Yatabe T, Kobayashi M, et al：Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy：tight glycemic control may be justified in order to avoid brittle diabetes. Biomed Mater Eng 23：109-116, 2013

27）花崎和弘：外科周術期の人工膵臓療法の現状と将来展望．医学のあゆみ268：576-580，2019

28）Hanazaki K, Tanioka N, Munekage M, et al：Closed-loop artificial endocrine pancreas from Japan. Artif Organs 45：958-967, 2021